Small molecule NF-κB pathway inhibitors in clinic

V Ramadass, T Vaiyapuri, V Tergaonkar - International journal of …, 2020 - mdpi.com
Nuclear factor kappa B (NF-κB) signaling is implicated in all major human chronic diseases,
with its role in transcription of hundreds of gene well established in the literature. This has …

Inflammatory pathophysiology as a contributor to myeloproliferative neoplasms

DAC Fisher, JS Fowles, A Zhou, ST Oh - Frontiers in immunology, 2021 - frontiersin.org
Myeloid neoplasms, including acute myeloid leukemia (AML), myeloproliferative neoplasms
(MPNs), and myelodysplastic syndromes (MDS), feature clonal dominance and remodeling …

Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML

RT Swords, S Coutre, MB Maris… - Blood, The Journal …, 2018 - ashpublications.org
Abstract Pevonedistat (TAK-924/MLN4924) is a novel inhibitor of NEDD8-activating enzyme
(NAE) with single-agent activity in relapsed/refractory acute myeloid leukemia (AML). We …

E1 enzymes as therapeutic targets in cancer

SH Barghout, AD Schimmer, E Barker - Pharmacological reviews, 2021 - Elsevier
Post-translational modifications of cellular substrates with ubiquitin and ubiquitin-like
proteins (UBLs), including ubiquitin, SUMOs, and neural precursor cell–expressed …

Analysis of PARP inhibitor toxicity by multidimensional fluorescence microscopy reveals mechanisms of sensitivity and resistance

J Michelena, A Lezaja, F Teloni, T Schmid… - Nature …, 2018 - nature.com
Exploiting the full potential of anti-cancer drugs necessitates a detailed understanding of
their cytotoxic effects. While standard omics approaches are limited to cell population …

NEDD8-conjugating enzyme E2s: critical targets for cancer therapy

L Zhou, X Lin, J Zhu, L Zhang, S Chen, H Yang… - Cell Death …, 2023 - nature.com
Abstract NEDD8-conjugating enzymes, E2s, include the well-studied ubiquitin-conjugating
enzyme E2 M (UBE2M) and the poorly characterized ubiquitin-conjugating enzyme E2 F …

Transcription factors: The fulcrum between cell development and carcinogenesis

Z Islam, AM Ali, A Naik, M Eldaw, J Decock… - Frontiers in …, 2021 - frontiersin.org
Higher eukaryotic development is a complex and tightly regulated process, whereby
transcription factors (TFs) play a key role in controlling the gene regulatory networks …

Emerging drug development technologies targeting ubiquitination for cancer therapeutics

G Veggiani, MCR Gerpe, SS Sidhu, W Zhang - Pharmacology & …, 2019 - Elsevier
Abstract Development of effective cancer therapeutic strategies relies on our ability to
interfere with cellular processes that are dysregulated in tumors. Given the essential role of …

Diverse and pivotal roles of neddylation in metabolism and immunity

T Zou, J Zhang - The FEBS Journal, 2021 - Wiley Online Library
Neddylation is one type of protein post‐translational modification by conjugating a ubiquitin‐
like protein neural precursor cell‐expressed developmentally downregulated protein 8 to …

New therapeutic strategies for adult acute myeloid leukemia

H Ishii, S Yano - Cancers, 2022 - mdpi.com
Simple Summary For almost 40 years, the combination of anthracyclines and cytarabine,
called 3+ 7, has been the standard of induction chemotherapy for the treatment of acute …